Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
 
Sponsors and Collaborators
Southwest Oncology Group
 
Contact

Click here and scroll down to view study contact and location info

 
Investigator
Mikkael A. Sekeres, MD, MS
The Cleveland Clinic
 
ClinicalTrials.gov Identifier